Skip to main content
. 2017 Aug 22;8(42):73087–73097. doi: 10.18632/oncotarget.20391

Figure 3. A sensitivity analysis of the incidence rate ratio, crude hazard ratio, and adjusted hazard ratio.

Figure 3

HHS Vulnerability Disclosure